Company: GANX
Filing Date: 2025-10-09
Form Type: 8-K
Source: 0001104659-25-098376
Chunk: 0

Company: Gain Therapeutics, Inc.
Filing Date: 2025-10-09
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 6, 2025, Eric Richman notified Gain
Therapeutics, Inc. (the “ Company”) that he was resigning from the Company’s Board of Directors (the “ Board”),
effective immediately. Mr. Richman’s resignation was not as a result of any disagreement with the Company on any matter
relating to the Company’s operations, policies or practices.

On October 7, 2025, in connection with Mr. Richman’s resignation,
the size of the Board was reduced from eight to seven.

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                             GAIN THERAPEUTICS, INC.                               
  Date: October 9, 2025      By:                          /s/ Gene Mack            
                             Name:                        Gene Mack                
                             Title:                       Chief Executive Officer